Please login to the form below

Not currently logged in
Email:
Password:

MSD/Roche expand hepatitis C partnership

MSD and Roche have signed a deal for the global promotion and marketing of Victrelis as part of a combination therapy for the hepatitis C virus

MSD (known as Merck within the US and Canada) and Roche have signed a deal for the global promotion and marketing of Victrelis as part of a combination therapy for the hepatitis C virus (HCV).

The deal follows the approval of the drug for marketing in the European Union, and expands upon a previous agreement between the two companies in May, 2011.

Under the revised terms, the two companies will work together in global markets, including Europe, Asia and Latin America, providing education for physicians and patients about HCV.

Previously, plans for promotion of the drug only covered the US, where the treatment was recently approved by the Food and Drug Administration.

Victrelis is intended for the treatment of chronic HCV, in combination with peginterferon alfa and ribavirin, in adult patients with compensated liver disease, including cirrhosis, who are previously untreated or who have failed previous interferon and ribavirin therapy.

It is an oral therapy that is taken three times a day with food. MSD acquired the drug as part of its 2009 takeover of Schering-Plough, which had brought the product through phase II development.

20th July 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics